Palantir NHS Data Furor Raises Questions For Future Government Contracts

Simply Wall St.02:39

Palantir Technologies (NasdaqGS:PLTR) is facing controversy over alleged broad access to identifiable UK patient data within an NHS England healthcare platform project. Contractors from Palantir and ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

J L 2025
28 minutes ago
J L 2025
This looks like another DOGE audit on health system budget usage / distribution. Palantir will add value to dig out inefficiencies and provide timely information for better health system.

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2635440342?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959","is_english":true,"pubTime":"2026-05-13 02:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2635440342","market":"sg","top_or_hot":-1,"title":"Palantir NHS Data Furor Raises Questions For Future Government Contracts","media":"Simply Wall St.","content":"<div>\n<p>Palantir Technologies (NasdaqGS:PLTR) is facing controversy over alleged broad access to identifiable UK patient data within an NHS England healthcare platform project. Contractors from Palantir and ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/software/nasdaq-pltr/palantir-technologies/news/palantir-nhs-data-furor-raises-questions-for-future-governme\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir NHS Data Furor Raises Questions For Future Government Contracts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir NHS Data Furor Raises Questions For Future Government Contracts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-13 02:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/software/nasdaq-pltr/palantir-technologies/news/palantir-nhs-data-furor-raises-questions-for-future-governme><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Palantir Technologies (NasdaqGS:PLTR) is facing controversy over alleged broad access to identifiable UK patient data within an NHS England healthcare platform project. Contractors from Palantir and ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/software/nasdaq-pltr/palantir-technologies/news/palantir-nhs-data-furor-raises-questions-for-future-governme\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://simplywall.st/stocks/us/software/nasdaq-pltr/palantir-technologies/news/palantir-nhs-data-furor-raises-questions-for-future-governme","article_id":"2635440342","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nasdaq-pltr/palantir-technologies/news/palantir-nhs-data-furor-raises-questions-for-future-governme","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2635440342","pubTimestamp":1778611183,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Palantir Technologies (NasdaqGS:PLTR) is facing controversy over alleged broad access to identifiable UK patient data within an NHS England healthcare platform project.\nContractors from Palantir and other firms were reportedly able to view sensitive information while working on the system.\nThe situation has drawn regulatory attention and questions about data privacy and security controls.\n\nPalantir builds data platforms used by governments and commercial clients, including healthcare...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Palantir NHS数据引发对未来政府合同的质疑","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/4209e69e6d2cbd0364e0e32944e4e978","symbols_score_info":{"PLOO":0.6,"PLTY":0.6,"PLTI":0.6,"PLTA":0.6,"PLT":0.6,"PLTU":0.6,"PLYY":0.6,"PLTD":0.6,"PLTR":1.98,"PLTZ":0.6,"PLTW":0.6,"PTIR":0.6,"PLTG":0.6},"content_text":"Palantir Technologies (NasdaqGS:PLTR) is facing controversy over alleged broad access to identifiable UK patient data within an NHS England healthcare platform project. Contractors from Palantir and other firms were reportedly able to view sensitive information while working on the system. The situation has drawn regulatory attention and questions about data privacy and security controls.  Palantir builds data platforms used by governments and commercial clients, including healthcare providers, to pull together and analyse large, complex datasets. For investors, the NHS England project highlights how work on critical public infrastructure can carry additional scrutiny compared with typical enterprise software contracts. As healthcare systems look to use data more effectively, the balance between utility and privacy is becoming more visible to regulators and the public. For Palantir, reputational risk around data handling can matter as much as product capability when competing for public sector contracts. Investors may want to watch how clearly the company explains its role, access controls and audit trails on this NHS project, along with any regulatory findings that might shape future government work or contract terms. Stay updated on the most important news stories for Palantir Technologies by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Palantir Technologies. NasdaqGS:PLTR 1-Year Stock Price Chart Is Palantir Technologies's balance sheet strong enough for future acquisitions? Dive into our detailed financial health analysis. AdvertisementQuick Assessment  ⚖️ Price vs Analyst Target: At US$136.89 vs an average analyst target of US$183.73, the stock sits about 25% below consensus. ⚖️ Simply Wall St Valuation: Simply Wall St currently assesses the stock as trading close to its estimated fair value. ✅ Recent Momentum: The share price is up 6.9% over the last 30 days.  There is only one way to know the right time to buy, sell or hold Palantir Technologies. Head to the Simply Wall St\ncompany report for the latest analysis of Palantir Technologies's fair value. Key Considerations  📊 This NHS data access controversy goes to the heart of Palantir's value proposition in sensitive government work, so it may influence how investors weigh contract durability against reputational questions. 📊 Watch for regulatory findings, any updates from NHS England on controls, and whether the issue affects Palantir's pipeline for other public sector projects. ⚠️ The key risk is that concerns around privacy or governance could limit future contracts in healthcare or other regulated areas, even if no formal penalties are imposed.  Dig Deeper For the full picture including more risks and rewards, check out the\ncomplete Palantir Technologies analysis. Alternatively, you can visit the\ncommunity page for Palantir Technologies to see how other investors believe this latest news will impact the company's narrative.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[{"id":563604392535024,"gmtCreate":1778631838846,"gmtModify":1778631846362,"author":{"id":"4194063502363152","authorId":"4194063502363152","name":"J L 2025","avatar":"https://community-static.tradeup.com/news/dc260c781ee7ea32ecf0b210514ef7ac","vip":1,"crmLevel":13,"crmLevelSwitch":0,"wearingBadges":[],"authorIdStr":"4194063502363152","idStr":"4194063502363152"},"htmlText":"This looks like another DOGE audit on health system budget usage / distribution. Palantir will add value to dig out inefficiencies and provide timely information for better health system.&nbsp;","listText":"This looks like another DOGE audit on health system budget usage / distribution. Palantir will add value to dig out inefficiencies and provide timely information for better health system.&nbsp;","text":"This looks like another DOGE audit on health system budget usage / distribution. Palantir will add value to dig out inefficiencies and provide timely information for better health system.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/563604392535024","repostId":2635440342,"repostType":2,"repost":{"id":"2635440342","kind":"highlight","pubTimestamp":1778611183,"share":"https://ttm.financial/m/news/2635440342?lang=en_US&edition=fundamental","pubTime":"2026-05-13 02:39","market":"sg","language":"en","title":"Palantir NHS Data Furor Raises Questions For Future Government Contracts","url":"https://stock-news.laohu8.com/highlight/detail?id=2635440342","media":"Simply Wall St.","summary":"Palantir Technologies (NasdaqGS:PLTR) is facing controversy over alleged broad access to identifiable UK patient data within an NHS England healthcare platform project.\nContractors from Palantir and other firms were reportedly able to view sensitive information while working on the system.\nThe situation has drawn regulatory attention and questions about data privacy and security controls.\n\nPalantir builds data platforms used by governments and commercial clients, including healthcare...","content":"<div>\n<p>Palantir Technologies (NasdaqGS:PLTR) is facing controversy over alleged broad access to identifiable UK patient data within an NHS England healthcare platform project. Contractors from Palantir and ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/software/nasdaq-pltr/palantir-technologies/news/palantir-nhs-data-furor-raises-questions-for-future-governme\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir NHS Data Furor Raises Questions For Future Government Contracts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir NHS Data Furor Raises Questions For Future Government Contracts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-13 02:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/software/nasdaq-pltr/palantir-technologies/news/palantir-nhs-data-furor-raises-questions-for-future-governme><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Palantir Technologies (NasdaqGS:PLTR) is facing controversy over alleged broad access to identifiable UK patient data within an NHS England healthcare platform project. Contractors from Palantir and ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/software/nasdaq-pltr/palantir-technologies/news/palantir-nhs-data-furor-raises-questions-for-future-governme\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959","relate_stocks":{},"source_url":"https://simplywall.st/stocks/us/software/nasdaq-pltr/palantir-technologies/news/palantir-nhs-data-furor-raises-questions-for-future-governme","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2635440342","content_text":"Palantir Technologies (NasdaqGS:PLTR) is facing controversy over alleged broad access to identifiable UK patient data within an NHS England healthcare platform project. Contractors from Palantir and other firms were reportedly able to view sensitive information while working on the system. The situation has drawn regulatory attention and questions about data privacy and security controls.  Palantir builds data platforms used by governments and commercial clients, including healthcare providers, to pull together and analyse large, complex datasets. For investors, the NHS England project highlights how work on critical public infrastructure can carry additional scrutiny compared with typical enterprise software contracts. As healthcare systems look to use data more effectively, the balance between utility and privacy is becoming more visible to regulators and the public. For Palantir, reputational risk around data handling can matter as much as product capability when competing for public sector contracts. Investors may want to watch how clearly the company explains its role, access controls and audit trails on this NHS project, along with any regulatory findings that might shape future government work or contract terms. Stay updated on the most important news stories for Palantir Technologies by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Palantir Technologies. NasdaqGS:PLTR 1-Year Stock Price Chart Is Palantir Technologies's balance sheet strong enough for future acquisitions? Dive into our detailed financial health analysis. AdvertisementQuick Assessment  ⚖️ Price vs Analyst Target: At US$136.89 vs an average analyst target of US$183.73, the stock sits about 25% below consensus. ⚖️ Simply Wall St Valuation: Simply Wall St currently assesses the stock as trading close to its estimated fair value. ✅ Recent Momentum: The share price is up 6.9% over the last 30 days.  There is only one way to know the right time to buy, sell or hold Palantir Technologies. Head to the Simply Wall St\ncompany report for the latest analysis of Palantir Technologies's fair value. Key Considerations  📊 This NHS data access controversy goes to the heart of Palantir's value proposition in sensitive government work, so it may influence how investors weigh contract durability against reputational questions. 📊 Watch for regulatory findings, any updates from NHS England on controls, and whether the issue affects Palantir's pipeline for other public sector projects. ⚠️ The key risk is that concerns around privacy or governance could limit future contracts in healthcare or other regulated areas, even if no formal penalties are imposed.  Dig Deeper For the full picture including more risks and rewards, check out the\ncomplete Palantir Technologies analysis. Alternatively, you can visit the\ncommunity page for Palantir Technologies to see how other investors believe this latest news will impact the company's narrative.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","news_type":1,"symbols_score_info":{"PLOO":0.6,"PLTY":0.6,"PLTI":0.6,"PLTA":0.6,"PLT":0.6,"PLTU":0.6,"PLYY":0.6,"PLTD":0.6,"PLTR":1.98,"PLTZ":0.6,"PLTW":0.6,"PTIR":0.6,"PLTG":0.6}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2635440342","isCrawlerRequest":true}